Product Registration

Under the Drugs and Cosmetics Act 1940 and Rules 1945 the Ministry of health and Family Welfare passed a set of laws giving authority to the Drugs Controller General of India (DCGI) to regulate the quality of drug product and drug substance imported into India or manufactured in India . The DCGI is the head of department of the Central Drugs Standard Control Organization of the Government of India responsible for approval of licences of specified categories of drugs .

The DCGI also sets standards for manufacturing, sales, import, and distribution of drugs in India. For Overseas manufacturers the DCGI requires the Drug and Medical Device manufacturers to register their products in India through an agent who must be a holder of a valid FDA license

Our Flagship Projects

Rifa Pharma supports its suppliers during the process of submitting applications for API’s , Finished Products and medical devices as per the client requirement. Our team of qualified experts will successfully review , compile and submit the regulatory documents for the international clients as per DCGI requirements . These applications include:

  • API Registration
  • Drug Product Registration
  • Medical Devices Registration
  • Cosmetic Registration
  • Test License
  • Import License

We Specialize in Helping our Customers to obtain the following:

  • Pre review of Documentation
  • Filing
  • Follow up and replies on query
  • Import clearance and submission of samples to the qualified Test lab
  • Coordination with the testing lab for certification

We Specialize in Helping our Customers to obtain the following:

  • Communicate to DCGI on behalf of our client
  • Prepare clarifications to questions from DCGI
  • Assistance in transfer of registration and testing fees to relevant authorities
  • Notify the client about the registration with DCGI

API Registration

Requirement :

Dossier as per DCGI Guidelines.

Time Taken :

8 to 12 months

  • Factory Registration $10000
  • Product Registration $5000 / Product
  • Factory Inspection ( if demanded by DCGI) $25000
  • New Drug Application $3500
  • Consulting Fees as per required service
Company tie ups
NextManufacturing
Tie-Ups
Under the Drugs and Cosmetics Act img Our Flagship Projects 1 We Specialize in helping our customers We Specialize in helping our customers 1 Api Registration
0
SCROLL DOWN

Product
Registration

down arrow

Under the Drugs and Cosmetics Act 1940 and Rules 1945 the Ministry of health and Family Welfare passed a set of laws giving authority to the Drugs Controller General of India (DCGI) to regulate the quality of drug product and drug substance imported into India or manufactured in India . The DCGI is the head of department of the Central Drugs Standard Control Organization of the Government of India responsible for approval of licences of specified categories of drugs .

slide 2

The DCGI also sets standards for manufacturing, sales, import, and distribution of drugs in India. For Overseas manufacturers the DCGI requires the Drug and Medical Device manufacturers to register their products in India through an agent who must be a holder of a valid FDA license.

Our Flagship Projects

Rifa Pharma supports its suppliers during the process of submitting applications for API’s , Finished Products and medical devices as per the client requirement. Our team of qualified experts will successfully review , compile and submit the regulatory documents for the international clients as per DCGI requirements . These applications include:

slide 1
■   API Registration
■   Drug Product Registration
■   Medical Devices Registration
■   Cosmetic Registration
■   Test License
■   Import License

API Registration

Requirement :

Dossier as per DCGI Guidelines.

 

Time Taken :

8 to 12 months

Category Fee 1
■   Factory Registration $10000
■   Product Registration $5000 / Product
■   Factory Inspection ( if demanded by DCGI) $25000
■   New Drug Application $3500

Contact Table

Medical Devices Expert

Connect with our Medical Devices Specialist for product guidance, technical support, and partnership inquiries.

Name

Contact Number

Email

Disha Desai +91 96194 94942 disha.desai@rifapharma.com


      Contact us

      Let us know how can we help?






      Disha Desai

      Medical Devices and
Packaging Solutions

      Ms. Desai has masterfully elevated the valuation of the Packaging and Medical Devices division, breaking barriers and unlocking new opportunities. She is an invaluable force with over 10+ years of expertise and a portfolio of 30+ customer companies. Her relentless hustle, strategic vision, and unwavering determination not only seize opportunities but create them, driving unprecedented growth and success.

      Ms Ujwala Parkhe

      Veterinary APIs & Premixes, Nutraceutical APIs

      Ms. Ujwala is a razor-sharp professional with an unwavering focus on delivering results. With deep expertise in the veterinary premix market, she ensures every promise and goal is achieved. Her tenacity, proficiency with active ingredients, and strategic foresight set her apart. Leading sales and new developments at Rifa Pharma, she drives innovation, sustainability, and impactful growth, making her a trusted advisor and partner in success.

      Dr Sanjay Loomba

      CEO at Rifa Pharma

      Our CEO and partner - Dr. Sanjay Loomba, a trauma surgeon and visionary leader, brings over 18 years of expertise in healthcare and the pharmaceutical industry. He has been instrumental in establishing advanced manufacturing facilities and optimising procurement for global markets. Currently, at Rifa Pharma, he focuses on driving innovation, enhancing operational excellence, promoting sustainability, and delivering patient-centric solutions that address the evolving needs of the healthcare sector.

      Neha Thakore

      Managing Partner at Rifa Pharma

      Neha is a dynamic and accomplished leader at Rifa Pharma, bringing over 25 years of expertise in the pharmaceutical industry, with a strong focus on operations. She is highly proficient in business development and regulatory affairs, successfully securing global approvals and driving impactful market expansion. As the Vice Chairperson of the IDMA Bulk Drug Committee, she plays a pivotal role in enhancing industry influence. Her comprehensive expertise extends across corporate governance, ESG strategy, and stakeholder engagement, ensuring sustainable growth and unwavering compliance excellence..

      Anant Thakore

      Founder

      Anant Thakore embodies resilience, vision, and leadership.Stepping in during a critical phase, he revolutionized the company,driving it to a remarkable $60 million indenting enterprise.A true pioneer in India’s pharmaceutical landscape,he played a crucial role in advancing anti-tuberculosis and antibiotic manufacturing. His groundbreaking achievements include becoming the first indigenous manufacturer of corticosteroids,solidifying his legacy as a transformative force in the industry.